Chandra Hermawan Manapa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chandra Hermawan Manapa has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Satrio Adi Wicaksono
Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia
3 shared publications - Widya Istanto Nurcahyo
Department of Anesthesiology and Intensive Care, Dr. Kariadi General Hospital, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
3 shared publications - Alesandro Ksatriaputra
Faculty of Medicine Universitas Diponegoro Semarang Indonesia
1 shared publication - Cindy Elfira Boom
Department of Anesthesia and Intensive Therapy, National Cardiovascular Center Harapan Kita, Jakarta
1 shared publication - Ginanto Auzan Adhyatmoko
Anaesthesiology Department and Intensive Therapy, Faculty of Medicine, Universitas Diponegoro, Dr. Kariadi General Hospital, Semarang, Central Java, Indonesia
1 shared publication Heru Dwi Jatmiko
Department of Anesthesiology and Intensive Care, Dr. Kariadi General Hospital, Semarang, Central Java, Indonesia
1 shared publication
Latest Publications
- Open Access
- 10 January 2025
- Published by Aga Khan University Hospital in Anaesthesia, Pain & Intensive Care
- Vol. 29 (7) , 796-807
Intrathecal atropine as an adjuvant in spinal anesthesia: a systematic review of efficacy and safety
Introduction: Spinal anesthesia (SA) is widely used for lower abdominal and limb surgeries due to its rapid onset and favorable safety profile. However, because of sympathetic blockade, it frequently results in bradycardia and hypotension, increasing the risk of perioperative complications and postoperative nausea and vomiting (PONV). Intrathecal atropine has shown potential as an adjuvant to counteract these effects and improve anesthesia outcomes. This review evaluates current evidence on the safety and efficacy of intrathecal atropine in SA. Methods: MEDLINE, EMBASE, CENTRAL, Scopus, ProQuest, and Google Scholar were searched for randomized controlled trials published in English up to April 2025 on intrathecal atropine as an adjuvant in SA. The primary outcome was PONV; secondary outcomes included sensory block onset, postoperative pain, and adverse effects. Risk of bias was assessed using the Cochrane RoB 2.0 tool. Results: Five RCTs involving 584 patients were included. Intrathecal atropine significantly reduced the incidence and severity of PONV in most studies (P < 0.05). However, it did not show significant effects on postoperative pain scores, sensory block onset, or hemodynamic parameters compared to control or other adjuvants. Adverse effects were generally mild and comparable across groups, though one study reported a higher incidence of pruritus with atropine (P < 0.001). No serious complications were observed. Nonetheless, study limitations included small sample sizes, non-standardized outcomes, and single-center designs with limited follow-up. Conclusions: Intrathecal atropine may reduce PONV after SA without serious adverse effects. However, its impact on pain, sensory block, and hemodynamics remains uncertain, warranting further large-scale, standardized trials. Abbreviations: GA: general anesthesia, RCT: randomized controlled trial, SA: Spinal anesthesia, PONV: postoperative nausea and vomiting Keywords: Adjuvant; Atropine; Complications; Intrathecal; Outcome; PONV; Postoperative Nausea and Vomiting; Spinal Anesthesia Citation: Pramadika T, Mochamat, Nurcahyo WI, Wicaksono SA, Saputra T, Manapa CH, Ksatriaputra A. Intrathecal atropine as an adjuvant in spinal anesthesia: a systematic review of efficacy and safety. Anaesth. pain intensive care 2025;29(7):796-807. DOI: 10.35975/apic.v29i7.2947
- 10 January 2025
- Published by Aga Khan University Hospital in Anaesthesia, Pain & Intensive Care
- Vol. 29 (7) , 796-807
Open AccessIntrathecal atropine as an adjuvant in spinal anesthesia: a systematic review of efficacy and safety
Introduction: Spinal anesthesia (SA) is widely used for lower abdominal and limb surgeries due to its rapid onset and favorable safety profile. However, because of sympathetic blockade, it frequently results in bradycardia and hypotension, increasing the risk of perioperative complications and postoperative nausea and vomiting (PONV). Intrathecal atropine has shown potential as an adjuvant to counteract these effects and improve anesthesia outcomes. This review evaluates current evidence on the safety and efficacy of intrathecal atropine in SA. Methods: MEDLINE, EMBASE, CENTRAL, Scopus, ProQuest, and Google Scholar were searched for randomized controlled trials published in English up to April 2025 on intrathecal atropine as an adjuvant in SA. The primary outcome was PONV; secondary outcomes included sensory block onset, postoperative pain, and adverse effects. Risk of bias was assessed using the Cochrane RoB 2.0 tool. Results: Five RCTs involving 584 patients were included. Intrathecal atropine significantly reduced the incidence and severity of PONV in most studies (P < 0.05). However, it did not show significant effects on postoperative pain scores, sensory block onset, or hemodynamic parameters compared to control or other adjuvants. Adverse effects were generally mild and comparable across groups, though one study reported a higher incidence of pruritus with atropine (P < 0.001). No serious complications were observed. Nonetheless, study limitations included small sample sizes, non-standardized outcomes, and single-center designs with limited follow-up. Conclusions: Intrathecal atropine may reduce PONV after SA without serious adverse effects. However, its impact on pain, sensory block, and hemodynamics remains uncertain, warranting further large-scale, standardized trials. Abbreviations: GA: general anesthesia, RCT: randomized controlled trial, SA: Spinal anesthesia, PONV: postoperative nausea and vomiting Keywords: Adjuvant; Atropine; Complications; Intrathecal; Outcome; PONV; Postoperative Nausea and Vomiting; Spinal Anesthesia Citation: Pramadika T, Mochamat, Nurcahyo WI, Wicaksono SA, Saputra T, Manapa CH, Ksatriaputra A. Intrathecal atropine as an adjuvant in spinal anesthesia: a systematic review of efficacy and safety. Anaesth. pain intensive care 2025;29(7):796-807. DOI: 10.35975/apic.v29i7.2947
- Open Access
- 30 March 2024
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 13 (3) , 1365-1370
Combination of small dosage midazolam and ketamine as intravenous premedication in pediatric patients: Comparative study of high dose vs. small dose
Introduction: Anesthesia and surgery cause anxiety in approximately 70% of children and are associated with many negative effects during and after surgery. High-dose premedication can expose children to various side effects. This study was aimed to compare the effectiveness of the combination of a small dose of midazolam 0.025 mg/kg and a dose of ketamine 0.25 mg/kg with a dose of midazolam 0.1 mg/kg and ketamine 1 mg/kg as intravenous premedication in pediatric patients. Methods: This study was an experimental analytical study. The study population was pediatric patients undergoing surgery under general anesthesia at RSUP DR. Kariadi Period October – November 2021. The research sample was 34 subjects obtained by simple random sampling technique and then divided into 2 groups. The research subjects were assessed on the Sedation Scale, Behavioral Scale and Parental Separation Scale before and after giving premedication and assessed the Anesthesia Mask Acceptance Scale and side effects, then compared between groups. Results: There was a significant difference in sedation score (p value 0.000), insignificant difference in behavior score and parental separation score in both groups (p value 0.786), a significant difference in mask acceptance score in group B (p value of 0.000). There was no difference in side effects in the two groups (p value > 0.05). Conclusion: The combination of low dose of midazolam and ketamine has been shown to be effective as an intravenous premedication in pediatric patients.
- 30 March 2024
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 13 (3) , 1365-1370
Open AccessCombination of small dosage midazolam and ketamine as intravenous premedication in pediatric patients: Comparative study of high dose vs. small dose
Introduction: Anesthesia and surgery cause anxiety in approximately 70% of children and are associated with many negative effects during and after surgery. High-dose premedication can expose children to various side effects. This study was aimed to compare the effectiveness of the combination of a small dose of midazolam 0.025 mg/kg and a dose of ketamine 0.25 mg/kg with a dose of midazolam 0.1 mg/kg and ketamine 1 mg/kg as intravenous premedication in pediatric patients. Methods: This study was an experimental analytical study. The study population was pediatric patients undergoing surgery under general anesthesia at RSUP DR. Kariadi Period October – November 2021. The research sample was 34 subjects obtained by simple random sampling technique and then divided into 2 groups. The research subjects were assessed on the Sedation Scale, Behavioral Scale and Parental Separation Scale before and after giving premedication and assessed the Anesthesia Mask Acceptance Scale and side effects, then compared between groups. Results: There was a significant difference in sedation score (p value 0.000), insignificant difference in behavior score and parental separation score in both groups (p value 0.786), a significant difference in mask acceptance score in group B (p value of 0.000). There was no difference in side effects in the two groups (p value > 0.05). Conclusion: The combination of low dose of midazolam and ketamine has been shown to be effective as an intravenous premedication in pediatric patients.
- Open Access
- 10 May 2023
- Published by Aga Khan University Hospital in Anaesthesia, Pain & Intensive Care
- Vol. 27 (5) , 486−490
Serratus anterior plane block for postoperative analgesia in modified radical mastectomy
Introduction: Serratus Anterior Plane (SAP) block can be used as part of multimodal analgesia, reducing the need for additional analgesia for 24 h postoperatively. The SAP block (SAPB) is easy to apply with a safe technique and low side effects. This study analyzes serratus anterior plane block as postoperative analgesia in Modified Radical Mastectomy (MRM) surgery by assessing the level of pain, side effects, and complications. Methods: This study was a double-blind randomized control trial (RCT) conducted on patients scheduled to undergo MRM, at Dr. Kariadi Hospital Semarang during August-October 2022. A total of 44 patients were enrolled, and divided into two groups; 22 patients in each group. The treatment group received SAPB and was compared with the control group of morphine 0.1 mg/kg, in terms of the numeric pain rating scale, at 4, 8, 12, and 24 h postoperatively, time and number of analgesic rescue doses, the incidence of PONV and pruritus within 24 h postoperatively. Independent T-test, Mann-Whitney, Chi-square, and Fischer tests were performed to analyze the data. P < 0.05 was considered significant. Results: The mean NRS at 4, 12, and 24 h postoperatively was lower in the SAPB group than in the control group (2.73 ± 0.77 vs. 3.23 ± 0.53; 1.77 ± 0.61 vs. 2.32 ± 0.48, and 1.45 ± 0.59 vs. 2.09 ± 0.61). The difference was statistically significant, e.g., P = 0.017, P = 0.003, and P = 0.001, respectively. Time to the first request of rescue analgesia was prolonged in the SAPB group than in the control group (398.86 ± 140.6 vs. 100.91 ± 10.3; P = 0.000). The mean rescue analgesic dose in the SAPB group was lower than in the control group (3.59 ± 1.56 vs. 8.55 ± 2.4; P = 0.000). The control group showed a higher incidence of PONV (68.2% vs. 18.2%, P = 0.01). There was no significant difference in the groups regarding the frequency of pruritus (P = 0.073). Conclusion: Serratus anterior plane block reduced pain significantly up to 24 h postoperatively compared to the control group. The patients in this group needed rescue analgesia after longer duration and needed lower doses of rescue analgesia. There was lower frequency of PONV than the control group. Abbreviations: MRM - Modified Radical Mastectomy; PONV – Postoperative Nausea and Vomiting; PMPS - Post-Mastectomy Pain Syndrome; PVB – Para Vertebral Block; SAP - Serratus Anterior Plane; VAS - Visual Analog Scale Key words: Serratus Anterior Plane Block; Breast Cancer; Modified Radical Mastectomy Citation: Mochamat, Arifin J, Pramadika T, ManapaCH, Istanto W, Wicaksono SA, Nugroho TE. Serratus anterior plane block for postoperative analgesia in modified radical mastectomy. Anaesth. pain intensive care 2023;27(5):486−490; DOI: 10.35975/apic.v27i5.2297 Received: January 05, 2023; Reviewed: January 18, 2023; Accepted: March 31, 2023
- 10 May 2023
- Published by Aga Khan University Hospital in Anaesthesia, Pain & Intensive Care
- Vol. 27 (5) , 486−490
Open AccessSerratus anterior plane block for postoperative analgesia in modified radical mastectomy
Introduction: Serratus Anterior Plane (SAP) block can be used as part of multimodal analgesia, reducing the need for additional analgesia for 24 h postoperatively. The SAP block (SAPB) is easy to apply with a safe technique and low side effects. This study analyzes serratus anterior plane block as postoperative analgesia in Modified Radical Mastectomy (MRM) surgery by assessing the level of pain, side effects, and complications. Methods: This study was a double-blind randomized control trial (RCT) conducted on patients scheduled to undergo MRM, at Dr. Kariadi Hospital Semarang during August-October 2022. A total of 44 patients were enrolled, and divided into two groups; 22 patients in each group. The treatment group received SAPB and was compared with the control group of morphine 0.1 mg/kg, in terms of the numeric pain rating scale, at 4, 8, 12, and 24 h postoperatively, time and number of analgesic rescue doses, the incidence of PONV and pruritus within 24 h postoperatively. Independent T-test, Mann-Whitney, Chi-square, and Fischer tests were performed to analyze the data. P < 0.05 was considered significant. Results: The mean NRS at 4, 12, and 24 h postoperatively was lower in the SAPB group than in the control group (2.73 ± 0.77 vs. 3.23 ± 0.53; 1.77 ± 0.61 vs. 2.32 ± 0.48, and 1.45 ± 0.59 vs. 2.09 ± 0.61). The difference was statistically significant, e.g., P = 0.017, P = 0.003, and P = 0.001, respectively. Time to the first request of rescue analgesia was prolonged in the SAPB group than in the control group (398.86 ± 140.6 vs. 100.91 ± 10.3; P = 0.000). The mean rescue analgesic dose in the SAPB group was lower than in the control group (3.59 ± 1.56 vs. 8.55 ± 2.4; P = 0.000). The control group showed a higher incidence of PONV (68.2% vs. 18.2%, P = 0.01). There was no significant difference in the groups regarding the frequency of pruritus (P = 0.073). Conclusion: Serratus anterior plane block reduced pain significantly up to 24 h postoperatively compared to the control group. The patients in this group needed rescue analgesia after longer duration and needed lower doses of rescue analgesia. There was lower frequency of PONV than the control group. Abbreviations: MRM - Modified Radical Mastectomy; PONV – Postoperative Nausea and Vomiting; PMPS - Post-Mastectomy Pain Syndrome; PVB – Para Vertebral Block; SAP - Serratus Anterior Plane; VAS - Visual Analog Scale Key words: Serratus Anterior Plane Block; Breast Cancer; Modified Radical Mastectomy Citation: Mochamat, Arifin J, Pramadika T, ManapaCH, Istanto W, Wicaksono SA, Nugroho TE. Serratus anterior plane block for postoperative analgesia in modified radical mastectomy. Anaesth. pain intensive care 2023;27(5):486−490; DOI: 10.35975/apic.v27i5.2297 Received: January 05, 2023; Reviewed: January 18, 2023; Accepted: March 31, 2023
- Open Access
- 12 April 2023
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 12 (2) , 1713-1717
Prevalence and characteristics of Postoperative Cognitive Dysfunction (POCD) in on-pump cardiac surgery patients at Dr. Kariadi General Hospital Semarang
Background: Postoperative Cognitive Dysfunction or POCD is a reversible decline in the cognitive function of patients after surgery. The risk factors for POCD are age, comorbidities, duration of CPB, intraoperative hypoperfusion, duration of ventilator use, and postoperative sedation are risk factors of POCD. This study aims to determine the prevalence and characteristics of postoperative cognitive dysfunction (POCD) in patients who undergo on-pump cardiac surgery at Dr. Kariadi General Hospital. Methods: This study's population was all patients undergoing on-pump cardiac surgery at Dr. RSUP. Kariadi in July 2021-December 2021. The study subject was 97 patients, obtained by total sampling technique. The study subjects were examined for cognitive function with MoCA-INA one day before surgery and the third day after surgery. Data were analyzed using SPSS version 23 for Windows. Results: There were 68 (70.1%) patients who experienced POCD and 29 (29.9%) patients who did not experience POCD. The median age of patients with POCD is 50 (18-68) years and 36 (18-63) years for patients without POCD. Based on MAP during CPB, patients with POCD had a median of 64 (51-80) minutes. In patients with POCD, the median length of CPB was 53 (22-92) minutes, and the median length of the aortic cross-clamp clamp was 35 (11-69) minutes. Conclusion: We found a high prevalence of POCD patients after on-pump cardiac surgery, as many as 70.1% at Dr. Kariadi General Hospital.
- 12 April 2023
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 12 (2) , 1713-1717
Open AccessPrevalence and characteristics of Postoperative Cognitive Dysfunction (POCD) in on-pump cardiac surgery patients at Dr. Kariadi General Hospital Semarang
Background: Postoperative Cognitive Dysfunction or POCD is a reversible decline in the cognitive function of patients after surgery. The risk factors for POCD are age, comorbidities, duration of CPB, intraoperative hypoperfusion, duration of ventilator use, and postoperative sedation are risk factors of POCD. This study aims to determine the prevalence and characteristics of postoperative cognitive dysfunction (POCD) in patients who undergo on-pump cardiac surgery at Dr. Kariadi General Hospital. Methods: This study's population was all patients undergoing on-pump cardiac surgery at Dr. RSUP. Kariadi in July 2021-December 2021. The study subject was 97 patients, obtained by total sampling technique. The study subjects were examined for cognitive function with MoCA-INA one day before surgery and the third day after surgery. Data were analyzed using SPSS version 23 for Windows. Results: There were 68 (70.1%) patients who experienced POCD and 29 (29.9%) patients who did not experience POCD. The median age of patients with POCD is 50 (18-68) years and 36 (18-63) years for patients without POCD. Based on MAP during CPB, patients with POCD had a median of 64 (51-80) minutes. In patients with POCD, the median length of CPB was 53 (22-92) minutes, and the median length of the aortic cross-clamp clamp was 35 (11-69) minutes. Conclusion: We found a high prevalence of POCD patients after on-pump cardiac surgery, as many as 70.1% at Dr. Kariadi General Hospital.